About Apicore
Apicore is a company based in Somerset (United States) founded in 2004 was acquired by Medicure in July 2017. Apicore has raised $720.12 thousand across 2 funding rounds from investors including Medicure, Knight Therapeutics and Signet Healthcare Partners. The company has 471 employees as of April 09, 2024. Apicore operates in a competitive market with competitors including Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
- Headquarter Somerset, United States
- Employees 471 as on 09 Apr, 2024
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Apicore Pharmaceuticals Private Limited
- Date of Incorporation 27 Jul, 2006
- Jurisdiction Vadodara, Gujarat, India
-
Annual Revenue
$15.24 M (USD)0as on Mar 31, 2023
-
Net Profit
-$1.28 M (USD)0as on Mar 31, 2023
-
EBITDA
$751.03 K (USD)0as on Mar 31, 2023
-
Total Equity Funding
$720.12 K (USD)
in 2 rounds
-
Latest Funding Round
$720.12 K (USD), Series A
Oct 05, 2016
-
Investors
Medicure
& 2 more
-
Employee Count
471
as on Apr 09, 2024
-
Acquired by
Medicure
(Jul 12, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Apicore
Apicore has successfully raised a total of $720.12K across 2 strategic funding rounds. The most recent funding activity was a Series A round of $720.12 thousand completed in October 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Apicore
Apicore has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Medicure, Knight Therapeutics and Signet Healthcare Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
PE firm investing in North America and Europe
|
Locked | Locked | Locked | |
|
Affordable therapeutics are developed and e-commerce pharmacy services are provided.
|
Locked | Locked | Locked | |
|
Prescription pharmaceuticals are acquired, licensed, and commercialized by the company.
|
Locked | Locked | Locked |
Investor details for Apicore
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Apicore
Investment portfolio details for Apicore
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Apicore
Detailed financials for Apicore
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Apicore Comparisons
Peer comparison for Apicore
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Apicore
Apicore operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical and biotechnology company
|
|
| Locked | Locked | Locked |
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
|
|
| Locked | Locked | Locked |
APIs and drug products are developed and valorized in pharmaceuticals.
|
|
| Locked | Locked | Locked |
APIs, intermediates, and biochemical reagents are developed and manufactured.
|
|
| Locked | Locked | Locked |
APIs are developed and manufactured for therapeutic areas.
|
|
| Locked | Locked | Locked |
Contract development, manufacturing, and analytical services for APIs are offered.
|
Detailed competitors of Apicore
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Apicore
Complete news archive for Apicore
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Apicore
Apicore was founded in 2004 and raised its 1st funding round 10 years after it was founded.
Apicore is headquartered in Somerset, United States.
Apicore is a funded company, having raised a total of $720.12K across 2 funding rounds to date.
As of Apr 09, 2024, the latest employee count at Apicore is 471.
Annual revenue of Apicore is $15.24M as on Mar 31, 2023.
Apicore was founded in 2004 in Somerset, United States, within the pharmaceutical chemicals sector. Active pharmaceutical ingredients (APIs) are produced, alongside custom synthesis for early-phase research. A portfolio of 100 API products is maintained, with synthesis capabilities encompassing carbohydrates, nucleosides, prostaglandins, diagnostic agents, liquid APIs, potent compounds, peptides, and complex small molecules. Operations extend to 16 countries globally.
Apicore's top competitors include Laurus Labs, Symbiotec and NGL Fine Chem.
Apicore has 3 investors. Key investors include Medicure, Knight Therapeutics, and Signet Healthcare Partners.